Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CPT2 | P23786 | 1/20 | 0.34 |
| ▸ | ACLY | P53396 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22390063 | 0.89 | TDP1 (0.30) | TDP1 | |
| SCHEMBL7931511 | 0.85 | — | — | |
| SCHEMBL3071716 | 0.81 | TDP1 (0.43) | TDP1CPT2ACLY | |
| SCHEMBL16397732 | 0.81 | CYP2D6 (0.34) | CPT2ACLY | |
| SCHEMBL28274392 | 0.79 | SMN1; SMN2 (0.43) | TDP1CPT2ACLY | |
| SCHEMBL2037914 | 0.77 | SLC22A6 (0.48) | TDP1CPT2ACLY | |
| SCHEMBL8540242 | 0.76 | FOLH1 (0.38) | TDP1CPT2ACLY | |
| SCHEMBL290603 | 0.76 | CPT2 (0.32) | CPT2ACLY | |
| SCHEMBL1553184 | 0.75 | TSHR (0.39) | CPT2ACLY | |
| SCHEMBL3647978 | 0.75 | CPT2 (0.32) | CPT2ACLY |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829131-B | Olanzapine transdermal drug delivery system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117815210-A | Risperidone transdermal application system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117157062-A | Transdermal patch for inhibiting drug crystallization and preparation method thereof | 新领医药技术(深圳)有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116829131-A | Olanzapine transdermal drug delivery system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-3130676-A1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | Rice University (US) | 2017-02-15 | — | — | EP | disclosed |
| EP-1781797-B1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | RICE UNIVERSITY (US) | 2016-10-19 | — | — | EP | disclosed |
| US-20160117440-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2016-04-28 | — | — | US | disclosed |
| EP-3004390-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | Memorial Sloan Kettering Cancer Center (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014194092-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2014-12-04 | — | — | WO | disclosed |
| US-7790416-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-20070184539-A1 | Mutant E. coli Strain with Increased Succinic Acid Production | RICE UNIVERSITY (US) | 2007-08-09 | — | — | US | disclosed |
| EP-1789569-A2 | HIGH SUCCINATE PRODUCING BACTERIA | Rice University (US) | 2007-05-30 | — | — | EP | disclosed |
| US-7223567-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2007-05-29 | — | — | US | disclosed |
| US-20060073577-A1 | High succinate producing bacteria | NATIONAL SCIENCE FOUNDATION | 2006-04-06 | — | — | US | disclosed |
| WO-2006034156-A2 | HIGH SUCCINATE PRODUCING BACTERIA | RICE UNIVERSITY (US) | 2006-03-30 | — | — | WO | disclosed |
| US-20060046288-A1 | Mutant E. coli strain with increased succinic acid production | NATIONAL SCIENCE FOUNDATION | 2006-03-02 | — | — | US | disclosed |
| US-6303351-B1 | GENERATING PREFERENTIAL COMPOUND; FEED BIOREATOR OXYGEN, CARBON SOURCE AND NITROGEN SOURCE, FERMENT, CONTINUOUSLY WITHDRAW FERMENTATION PRODUCT AND RECOVER PREFERENTIAL COMPOUND | Anastassiadis, Savas | 2001-10-16 | — | — | US | disclosed |
| US-4075093-A | PERMSELECTIVE MEMBRANE | JOH. A. BENCKISER GMBH (DT) | 1978-02-21 | — | — | US | disclosed |